Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · RPGLIFE

RPG LIFESCI

HealthcarePharmaceuticals & Biotechnology₹4142 cr market cap
₹2604.30 ▲ +4.07% today As of 19 Nov 2026
52-week low ₹1744.0052-week high ₹3089.20

-19.0% from the 52-week high · +43.5% above the low

RPG Life Sciences Ltd. is engaged in the development, manufacture, and market of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2008-06-10. The firm operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.

The short version. Return on equity was 19.0% in Mar 2026. Promoter holding was 72.95% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

RPG LIFESCI trades 19.0% below its 52-week high and 43.5% above its 52-week low.

Change over period: —

1M-12.0%
3M-6.2%
6M+8.8%
1Y+8.8%

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025
Revenue212196177180
Net profit27313022
Net margin %12.615.716.912.3
EPS (₹)16.0818.618.0813.38

Annual

FY2026
Revenue708
Net profit115
Net margin %16.3
EPS (₹)69.64

3 · The quality

How well does it turn capital into profit?

Return on equity was 19.0% in Mar 2026; debt to equity is 0.03.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %19.0———
Return on capital %24.5———
EBITDA margin %24.1———
Net margin %15.7———

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.03
Interest cover174.3x
Current ratio3.52
P/E ratio37.4

4 · The owners

Who holds it, and are they adding?

Promoter holding72.95%

Unchanged over 8 quarters.

Foreign institutions0.87%

Down 0.43 pts over 8 quarters.

Domestic institutions9.93%

Up 3.87 pts over 8 quarters.

Mutual fund schemes5

+1 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter72.9572.9572.9572.9572.9572.9572.9572.950.0
FII1.31.451.351.111.00.870.950.87-0.43
DII6.066.146.486.77.047.458.679.93+3.87
Public19.6919.4619.2219.2419.0118.7317.4216.25-3.44

Mutual fund holdings · Oct 2026

5 schemes hold this stock

4 the month before.

  • Motilal Oswal BSE Healthcare ETF0.07% of NAV
  • Bandhan BSE Healthcare Index Fund0.07% of NAV
  • Motilal Oswal BSE 1000 Index Fund0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for RPG LIFESCI are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about RPG LIFESCI

What is the RPG LIFESCI share price?

RPG LIFESCI (RPGLIFE) last closed at ₹2,604.30, up 4.07% on the day. Its 52-week range is ₹1,744.00 to ₹3,089.20.

What is the market cap of RPG LIFESCI ?

RPG LIFESCI has a market capitalisation of about ₹4,142 crore. Its price-to-earnings ratio is 37.4.

How are RPG LIFESCI 's latest results?

Return on equity was 19.0% in Mar 2026. Promoter holding was 72.95% in Sep 2026, up 0.00 points over 8 quarters.

Who owns RPG LIFESCI ?

As of Sep 2026, shareholding was: Promoter 72.95%, FII 0.87%, DII 9.93%, Public 16.25%.

How many mutual funds hold RPG LIFESCI ?

5 mutual fund schemes held RPG LIFESCI in October 2026. That compares with 4 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 09 Jul 2026 · Final Dividend - Rs. 24
  • 27 Jun 2025 · Final Dividend - Rs. 20
  • 27 Jun 2025 · Special Dividend - Rs. 4
  • 28 Jun 2024 · Final Dividend - Rs. 16
  • 21 Jul 2023 · Final Dividend - Rs. 12
  • 14 Jul 2022 · Final Dividend - Rs. 9.6

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.